NYSE · LLY
Eli Lilly and Company
$1,422.92+$49.22 (+3.58%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 1.85% below the high.
Loading market information…
OTC · GDNSF · USD
Stock price, earnings
Quote as of Jul 23, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Goodness Growth Holdings, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Goodness Growth Holdings, Inc. is a U.S.-based cannabis firm distinguished by its physician-guided approach. The company's operations span cultivation of cannabis in eco-conscious greenhouses, the production of pharmaceutical-quality extracts, and the distribution of these products. Distribution occurs via its proprietary Green Goods and other Goodness Growth-branded retail outlets, alongside sales through independent third-party dispensaries. As of March 11, 2022, Goodness Growth managed a retail footprint of 18 dispensaries, with locations comprising two in Maryland, eight in Minnesota, four in New Mexico, and four in New York. Additionally, it provides wholesale cannabis offerings to third-party vendors across Arizona, Maryland, Minnesota, and New York. The organization rebranded from Vireo Health International Inc. to its current name, Goodness Growth Holdings, Inc., in June 2021. Its corporate headquarters are situated in Minneapolis, Minnesota.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:41 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Aug 14, 2023 |
| -$0.06-20.0% vs estimate |
| $20.20M+5.19% vs estimate |
THE ANALYST VIEW
2 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,422.92+$49.22 (+3.58%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 1.85% below the high.
$275.30+$0.10 (+0.03%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 2.38% below the high.
$294.71+$3.92 (+1.35%)
AbbVie Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.35% below the high.
$150.14+$3.81 (+2.6%)
Merck & Co., Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.32% below the high.
$408.70-$2.21 (-0.54%)
UnitedHealth Group Incorporated’s quoted price sits in the upper half of its reported 52-week range, 11.46% below the high.
$693.43-$15.75 (-2.22%)
Thermo Fisher Scientific Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.59% below the high.
$0.33-$0.01 (-3.25%)
Grown Rogue International Inc.’s quoted price sits in the lower half of its reported 52-week range, 36.61% below the high.
$0.39-$0.01 (-3.53%)
Ascend Wellness Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 67.9% below the high.
